1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址：

https://onlinelibrary.wiley.com/journal/25233548

4、投稿系统：https://wiley.atyponrex.com/journal/CAC2

5、主办单位网址：https://www.sysucc.org.cn/

（中山大学肿瘤防治中心）

6、官网邮箱：cancercommun@sysucc.org.cn

7、期刊刊期：月刊，一年出版12期。

8、官方微信公众号：

Cancer Communications（CancerCommunications）

2024年10月31日星期四

《癌症通讯（英文）》（Cancer Communications）

期刊简介

关于Cancer Communications

Cancer Communications（前刊名Chinese Journal of Cancer，2018年变更为现刊名）由中山大学肿瘤防治中心主办，主编徐瑞华教授。该刊2020年1月1日起与国际著名三大学术出版社之一Wiley合作出版。

Cancer Communications （CC，原刊名Chinese Journal of Cancer）创刊于1982 年，是中山大学肿瘤防治中心主办的肿瘤学专业期刊，主编徐瑞华教授。CC 为 Pubmed、SCI 收录期刊，2021 年公布的 JCR 影响因子为 10.392。

CC 一直秉承“搭建国际化肿瘤学研究交流平台，促进学科发展”的办刊宗旨，坚持质量第一，社会效益第一的办刊理念，影响力不断扩大：2013-2019连续 7 年获得“中国最具国际影响力学术期刊”称号。

CC 坚持国际化办刊理念，不断拓展杂志的国际稿源，遴选国际知名学者担任评审专家；作为美中抗癌协会（USCACA）会刊，CC 获得了众多海外资深学者的大力支持；2015年至2019年与 Springer-Nature 旗下的BioMed Central合作出版，2020年开始与Wiley合作出版，开拓了CC 的国际化前进道路。

目前，Cancer Communications 被世界权威生物医学检索系统PubMed/Medline、Scopus和国际最大的开放获取期刊目录DOAJ等重要数据库收录；采用国际同行评议、完全开放获取的办刊模式。迄今为止，Cancer Communications 已发表来自88个国家/地区近2106个机构（按照所有作者国家与机构计算）的论文千余篇，被108个国家/地区的研究机构引用，积年累计总被引频次超过23000次；发表的多篇文章被领域内著名期刊Nature,

Science,  Cell,  Lancet,  The New England Journal of Medicine, Cancer

Cell, Stem Cells, Nature Reviews Cancer, Nature Reviews Neurology,

Nature Reviews Urology 等引用。

《癌症通讯（英文）》（Cancer Communications）作者指南

【官网信息】

Author Guidelines

1. Submission

2. Aims and Scope

3. Manuscript Categories and Requirements

4. Preparing the Submission

5. Editorial Policies and Ethical Considerations

6. Author Licensing

7. Publication Process after Acceptance

8. Post Publication

9. Editorial Office Contact Details

1. SUBMISSION

Authors

should kindly note that submission implies that the content has not

been published or submitted for publication elsewhere except as a brief

abstract in the proceedings of a scientific meeting or symposium.

New

submissions should be made via the Research Exchange submission portal

https://wiley.atyponrex.com/journal/CAC2. You may check the status of

your submission at any time by logging on to submission.wiley.com and

clicking the “My Submissions” button. For technical help with the

submission system, please review our FAQs or contact

submissionhelp@wiley.com.

Free Format submission

Cancer Communications now offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

Your

manuscript: this should be an editable file including text, figures,

and tables, or separate files – whichever you prefer. All required

sections should be contained in your manuscript, including abstract,

introduction, methods, results, and conclusions. Figures and tables

should have legends. Figures should be uploaded in the highest

resolution possible. References may be submitted in any style or format,

as long as it is consistent throughout the manuscript. Supporting

information should be submitted in separate files. If the manuscript,

figures or tables are difficult for you to read, they will also be

difficult for the editors and reviewers, and the editorial office will

send it back to you for revision. Your manuscript may also be sent back

to you for revision if the quality of English language is poor.

An

ORCID ID, freely available at https://orcid.org. (Why is this

important? Your article, if accepted and published, will be attached to

your ORCID profile. Institutions and funders are increasingly requiring

authors to have ORCID IDs.)

The title page of the manuscript, including:

Your

co-author details, including affiliation and email address. (Why is

this important? We need to keep all co-authors informed of the outcome

of the peer review process.)

Statements

relating to our ethics and integrity policies, which may include any of

the following (Why are these important? We need to uphold rigorous

ethical standards for the research we consider for publication):

data availability statement

funding statement

conflict of interest disclosure

ethics approval statement

patient consent statement

permission to reproduce material from other sources

clinical trial registration

Data protection:

By

submitting a manuscript to or reviewing for this publication, your

name, email address, and affiliation, and other contact details the

publication might require, will be used for the regular operations of

the publication, including, when necessary, sharing with the publisher

(Wiley) and partners for production and publication. The publication and

the publisher recognize the importance of protecting the personal

information collected from users in the operation of these services, and

have practices in place to ensure that steps are taken to maintain the

security, integrity, and privacy of the personal data collected and

processed. You can learn more at

https://authorservices.wiley.com/statements/data-protection-policy.html.

更多详情：

https://onlinelibrary.wiley.com/page/journal/25233548/homepage/author-guidelines